Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Apollo Endosurgery Sees FY22 Revenue Between $75M and $76M vs $73.95M Est.

Author: Benzinga Newsdesk | November 01, 2022 04:11pm

Posted In: APEN